Remove Pharma Remove Pharmaceutical products Remove Safety Remove Side effects
article thumbnail

Why There's No Such Thing as a 'Safe' Drug?

Contrarian Sales Techniques

This includes potential side effects or adverse reactions to medications. Clinical studies play an essential role in determining the safety and efficacy of new drugs before they can be approved for the public. This is before a drug can be approved for public use.

article thumbnail

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

Understanding Sample Bags At its core, a sample bag is much more than a mere carrying case; it's a tailored solution specifically designed for the unique needs of pharmaceutical sales representatives. In the realm of pharma, where the presentation of drug samples is as critical as the information relayed, these bags serve a pivotal role.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Practical advice for Early Scientific Advice (ESA) in HTA submissions

pharmaphorum

Payers must take into consideration not only the clinical efficacy of a drug, but also its safety profile, side effects, and cost-effectiveness, among other factors.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. The demand for commercial CAR products is very high due to its unprecedented success in treatment of patients with very advanced haematological malignancies.

article thumbnail

Pharma coming to moral crossroads

World of DTC Marketing

” The speedy vaccine development protects pharma companies from litigation if patients get sick from nasty side effects but morally this is a serious question of judgment. But what does that billion dollars buy as far as approving the product for market? J&J received more than $1 billion from the U.S.